| Proteon Therapeutics advances drug candidate, sale to Novartis - Bizjournals.com |
|
|
Bizjournals.com ... that permanently dilates blood vessels, is aimed at reducing the failure of hemodialysis access sites, which are the surgical connections of arteries and veins that allow patients to be hooked up to dialysis machines for periodic blood filtering. ... Proteon Therapeutics Initiates Patient Enrollment in Phase 2 Clinical Study of |